Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/09/17
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 07/31/13
Due: 07/31/14
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of AggreGuide A-100 (ADP) Assay | NCT03111420 | Aggredyne, Inc. | user2@example.com | None | 2017-01-09 | 2018-06-30 | 2019-06-30 | - | - | 2025-07-14 |
| Aggreguide A-100 ADP Assay Evaluation | NCT02112539 | Aggredyne, Inc. | user2@example.com | None | 2014-03-31 | 2014-08-31 | 2015-08-31 | - | - | 2025-07-14 |
| AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction | NCT01915407 | Aggredyne, Inc. | user2@example.com | None | 2013-04-30 | 2013-07-31 | 2014-07-31 | - | - | 2025-07-14 |